These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36144820)

  • 1. Multipotent Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease: Synthesis, Biological Analysis and Molecular Docking Study of Benzimidazole-Based Thiazole Derivatives.
    Hussain R; Ullah H; Rahim F; Sarfraz M; Taha M; Iqbal R; Rehman W; Khan S; Shah SAA; Hyder S; Alhomrani M; Alamri AS; Abdulaziz O; Abdelaziz MA
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis, In Vitro Biological Evaluation and In Silico Molecular Docking Study of Benzimidazole-Based Oxazole Analogues: A Promising Acetylcholinesterase and Butyrylcholinesterase Inhibitors.
    Hussain R; Rahim F; Ullah H; Khan S; Sarfraz M; Iqbal R; Suleman F; Al-Sadoon MK
    Molecules; 2023 Oct; 28(20):. PubMed ID: 37894494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and molecular docking simulation of new benzimidazole-thiazole hybrids as cholinesterase inhibitors.
    Dawood DH; Srour AM; Omar MA; Farghaly TA; El-Shiekh RA
    Arch Pharm (Weinheim); 2024 Jan; 357(1):e2300201. PubMed ID: 37937360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent development and strategies towards target interactions: Synthesis, characterization and in silico analysis of benzimidazole based thiadiazole as potential anti-Alzheimer agents.
    Khan S; Hussain R; Iqbal T; Rahim F; Khan Y
    Biochem Biophys Res Commun; 2024 Sep; 726():150201. PubMed ID: 38924881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of Benzimidazole-Based Analogs as Anti Alzheimer's Disease Compounds and Their Molecular Docking Studies.
    Adalat B; Rahim F; Taha M; Alshamrani FJ; Anouar EH; Uddin N; Shah SAA; Ali Z; Zakaria ZA
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33092223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of New Triazole-Based Thiosemicarbazone Derivatives as Anti-Alzheimer's Disease Candidates: Evidence-Based In Vitro Study.
    Rahim F; Ullah H; Taha M; Hussain R; Sarfraz M; Iqbal R; Iqbal N; Khan S; Ali Shah SA; Albalawi MA; Abdelaziz MA; Alatawi FS; Alasmari A; Sakran MI; Zidan N; Jafri I; Khan KM
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Molecular Docking of New Bis-Thiazolidinone-Based Chalcone Analogs as Effective Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
    Hussain R; Rahim F; Rehman W; Taha M; Khan S; Zaman K; Adnan Ali Shah S; Wadood A; Imran S; Abdellatif MH
    Chem Biodivers; 2022 Oct; 19(10):e202200323. PubMed ID: 35997224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, DFT Studies, Molecular Docking and Biological Activity Evaluation of Thiazole-Sulfonamide Derivatives as Potent Alzheimer's Inhibitors.
    Khan S; Ullah H; Taha M; Rahim F; Sarfraz M; Iqbal R; Iqbal N; Hussain R; Ali Shah SA; Ayub K; Albalawi MA; Abdelaziz MA; Alatawi FS; Khan KM
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, biological evaluation and molecular docking of cyclic biguanidine compounds as cholinesterase inhibitors.
    Gungor O; Kose M
    J Biomol Struct Dyn; 2023 Dec; 41(20):10885-10899. PubMed ID: 36537267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, and Structure-Activity Relationships of Thiazole Analogs as Anticholinesterase Agents for Alzheimer's Disease.
    Sağlık BN; Osmaniye D; Acar Çevik U; Levent S; Kaya Çavuşoğlu B; Özkay Y; Kaplancıklı ZA
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32962239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease.
    Eissa KI; Kamel MM; Mohamed LW; Doghish AS; Alnajjar R; Al-Karmalawy AA; Kassab AE
    Drug Dev Res; 2023 Aug; 84(5):937-961. PubMed ID: 37067008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO-B dual inhibitors.
    Osmaniye D; Evren AE; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
    Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100450. PubMed ID: 34931332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, and Biological Evaluation of Novel Indanone Derivatives as Cholinesterase Inhibitors for Potential Use in Alzheimer's Disease.
    Etemadi A; Hemmati S; Shahrivar-Gargari M; Abibiglue YT; Bavili A; Hamzeh-Mivehroud M; Dastmalchi S
    Chem Biodivers; 2023 Aug; 20(8):e202300075. PubMed ID: 37458518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors.
    Alpan AS; Parlar S; Carlino L; Tarikogullari AH; Alptüzün V; Güneş HS
    Bioorg Med Chem; 2013 Sep; 21(17):4928-37. PubMed ID: 23891231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
    Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
    Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological Evaluation, Molecular Docking, and SAR Studies of Novel 2-(2,4-Dihydroxyphenyl)-1
    Matysiak J; Skrzypek A; Karpińska M; Czarnecka K; Szymański P; Bajda M; Niewiadomy A
    Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31842463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
    Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
    Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential acetylcholinesterase inhibitors to treat Alzheimer's disease.
    Saud A; Krishnaraju V; Taha A; Kalpana K; Malarkodi V; Durgaramani S; Vinoth Prabhu V; Saleh FA; Ezhilarasan S
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2522-2537. PubMed ID: 38567612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
    Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
    Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.